Results 201 to 210 of about 10,048,421 (237)
Efficacy of Cross-Linked Collagen Membranes for Bone Regeneration: In Vitro and Clinical Studies. [PDF]
Baek SH +5 more
europepmc +1 more source
Beyond the average: why data spread matters in clinical studies. [PDF]
Politi MT, Ferreira JC, Patino CM.
europepmc +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
2005
Recognizing that type 1 diabetes was characterized not only by insulin deficiency, but also by amylin deficiency, Cooper (Cooper, 1991) predicted that certain features of the disease could be related thereto, and he proposed amylin/insulin co-replacement therapy. Although the early physiological rationale was flawed, the idea that glucose control could
openaire +3 more sources
Recognizing that type 1 diabetes was characterized not only by insulin deficiency, but also by amylin deficiency, Cooper (Cooper, 1991) predicted that certain features of the disease could be related thereto, and he proposed amylin/insulin co-replacement therapy. Although the early physiological rationale was flawed, the idea that glucose control could
openaire +3 more sources
Retrospective clinical studies
Journal of Pediatric Urology, 2016Patient-based retrospective studies are most often based on one unique patient cohort from one particular institution. At best, they can give rise to observations leading to future prospective studies and new hypotheses. The study by Pamela Ellsworth et al.
openaire +2 more sources
Drugs of Today, 1998
Zolmitriptan, a selective 5-HT(1B/D) agonist was developed for the acute treatment of migraine. Dose-finding studies show a clearly defined dose response curve for the oral formulation with onset of efficacy demonstrated within 45 min of dosing. Clinical trials support its efficacy in all types of migraine, with excellent safety and tolerability in ...
openaire +2 more sources
Zolmitriptan, a selective 5-HT(1B/D) agonist was developed for the acute treatment of migraine. Dose-finding studies show a clearly defined dose response curve for the oral formulation with onset of efficacy demonstrated within 45 min of dosing. Clinical trials support its efficacy in all types of migraine, with excellent safety and tolerability in ...
openaire +2 more sources

